More intelligence articles

Trust me, I’m from pharma

Chris Ross, with the help of five industry thought leaders, explores how the industry can enhance its public reputation by focusing on making a difference – rather than just making

Bluebird Bio: on the cusp of a gene therapy revolution

Nick Leschly talks to PME about Bluebird's remarkable gene therapy pipeline and why it’s filing first in Europe.

Happy 70th birthday NHS: the next 70 need to be very different

The UK’s NHS is loved by the British public, while social care is under appreciated and underfunded. The new health secretary is being urged to remedy this to create a

The rise of vertical integration in the US payer landscape

Is it a solution to addressing the challenges of the value-based marketplace?

Can new data aggregators shift the balance of power away from pharma?

Making data a core competence

Mylan sees the UK paving the way for an insulin game changer

As biosimilars surge into the insulin market, governments are urged to seize ‘the opportunity of the century’

Cutting through the noise

Why creativity = impact in medical education

Indefinable, incomparable and enduring: the value of creativity

Building an environment that encourages, nurtures and harnesses creativity

Diversity and inclusion in the pharma industry

Is there equality in the workplace?

Is flexible working the future?

How adopting a flexible approach allows access for senior talent

‘How is your day?’

The initiative that shows how plasma protein therapies improve lives

Advancing women in healthcare

Fostering the next generation of leaders

30 Women Leaders in UK Healthcare (part 3)

Continuing our special feature on Women Leaders in UK Healthcare

30 Women Leaders in UK Healthcare

The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future

30 Women Leaders in UK Healthcare (part 2)

Part two of our list of thirty women leaders 11-20